The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Immunogenic Cell Death Induction by Ionizing Radiation
Open accessAbstract
Immunogenic cell death (ICD) is a form of regulated cell death (RCD) induced by various stresses and produces antitumor immunity via damage-associated molecular patterns (DAMPs) release or exposure, mainly including high mobility group box 1 (HMGB1), calreticulin (CRT), adenosine triphosphate (ATP), and heat shock proteins (HSPs). Emerging evidence has suggested that ionizing radiation (IR) can induce ICD, and the dose, type, and fractionation of irradiation influence the induction of ICD. At present, IR-induced ICD is mainly verified in vitro in mice and there is few clinical evidence about it. To boost the induction of ICD by IR, some strategies have shown synergy with IR to enhance antitumor immune response, such as hyperthermia, nanoparticles, and chemotherapy. In this review, we focus on the molecular mechanisms of ICD, ICD-promoting factors associated with irradiation, the clinical evidence of ICD, and immunogenic forms of cell death. Finally, we summarize various methods of improving ICD induced by IR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Broadening horizons: the role of ferroptosis in cancer
Chen, X., Kang, R., Kroemer, G., & Tang, D. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00462-0 · Cited by 2,897
CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy
Wang, W., Green, M., Choi, J. E., Gijón, M., Kennedy, P. D., Johnson, J. K., Liao, P., Lang, X., Kryczek, I., Sell, A., et al. (2019) · Nature · doi:10.1038/s41586-019-1170-y · Cited by 2,880
Self-citationThe role of ferroptosis in ionizing radiation-induced cell death and tumor suppression
Lei, G., Zhang, Y., Koppula, P., Liu, X., Zhang, J., Lin, S. H., Ajani, J. A., Xiao, Q., Liao, Z., Wang, H., et al. (2020) · Cell Research · doi:10.1038/s41422-019-0263-3 · Cited by 1,318
Self-citationFerroptosis, necroptosis, and pyroptosis in anticancer immunity
Tang, R., Xu, J., Zhang, B., Liu, J., Liang, C., Hua, J., Meng, Q., Yu, X., & Shi, S. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00946-7 · Cited by 1,273
Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion
Friedmann Angeli, J. P., Krysko, D. V., & Conrad, M. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0149-1 · Cited by 1,259
Detection of immunogenic cell death and its relevance for cancer therapy
Fucikova, J., Kepp, O., Kasikova, L., Petroni, G., Yamazaki, T., Liu, P., Zhao, L., Spisek, R., Kroemer, G., & Galluzzi, L. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-03221-2 · Cited by 1,138
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Galluzzi, L., Vitale, I., Warren, S., Adjemian, S., Agostinis, P., Martinez, A. B., Chan, T. A., Coukos, G., Demaria, S., Deutsch, E., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000337 · Cited by 1,119
Lang, X., Green, M. D., Wang, W., Yu, J., Choi, J. E., Jiang, L., Liao, P., Zhou, J., Zhang, Q., Dow, A., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0338 · Cited by 1,047
Nanoparticle‐Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy
Duan, X., Chan, C., & Lin, W. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201804882 · Cited by 1,033
Targeting immunogenic cell death in cancer
Ahmed, A., & Tait, S. W. G. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12851 · Cited by 930
Sharabi, A. B., Lim, M., DeWeese, T. L., & Drake, C. G. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00007-8 · Cited by 899
Immunogenic cell death in cancer therapy: Present and emerging inducers
Zhou, J., Wang, G., Chen, Y., Wang, H., Hua, Y., & Cai, Z. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14356 · Cited by 719
Nanoparticle‐Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy
Chen, Q., Chen, J., Yang, Z., Xu, J., Xu, L., Liang, C., Han, X., & Liu, Z. (2019) · Advanced Materials · doi:10.1002/adma.201802228 · Cited by 661
Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death
Golden, E. B., Frances, D., Pellicciotta, I., Demaria, S., Helen Barcellos-Hoff, M., & Formenti, S. C. (2014) · OncoImmunology · doi:10.4161/onci.28518 · Cited by 624
Radiation-Induced Lipid Peroxidation Triggers Ferroptosis and Synergizes with Ferroptosis Inducers
Ye, L. F., Chaudhary, K. R., Zandkarimi, F., Harken, A. D., Kinslow, C. J., Upadhyayula, P. S., Dovas, A., Higgins, D. M., Tan, H., Zhang, Y., et al. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.9b00939 · Cited by 521
Self-citationRecent Advances in Hyperthermia Therapy‐Based Synergistic Immunotherapy
Chang, M., Hou, Z., Wang, M., Li, C., & Lin, J. (2021) · Advanced Materials · doi:10.1002/adma.202004788 · Cited by 450
Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses
Garg, A. D., & Agostinis, P. (2017) · Immunological Reviews · doi:10.1111/imr.12574 · Cited by 440
Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?
Bernstein, M. B., Krishnan, S., Hodge, J. W., & Chang, J. Y. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.30 · Cited by 399
Immunological impact of cell death signaling driven by radiation on the tumor microenvironment
Rodriguez-Ruiz, M. E., Vitale, I., Harrington, K. J., Melero, I., & Galluzzi, L. (2020) · Nature Immunology · doi:10.1038/s41590-019-0561-4 · Cited by 385
Molecular Mechanisms of Radiation-Induced Cancer Cell Death: A Primer
Sia, J., Szmyd, R., Hau, E., & Gee, H. E. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00041 · Cited by 378
Snyder, A. G., Hubbard, N. W., Messmer, M. N., Kofman, S. B., Hagan, C. E., Orozco, S. L., Chiang, K., Daniels, B. P., Baker, D., & Oberst, A. (2019) · Science Immunology · doi:10.1126/sciimmunol.aaw2004 · Cited by 374
Ding, B., Zheng, P., Jiang, F., Zhao, Y., Wang, M., Chang, M., Ma, P., & Lin, J. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202005111 · Cited by 341
Wang, L., Guan, R., Xie, L., Liao, X., Xiong, K., Rees, T. W., Chen, Y., Ji, L., & Chao, H. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202013987 · Cited by 289
Huang, Z., Wang, Y., Yao, D., Wu, J., Hu, Y., & Yuan, A. (2021) · Nature Communications · doi:10.1038/s41467-020-20243-8 · Cited by 272
Immunogenic cell death in anticancer chemotherapy and its impact on clinical studies
Wang, Q., Ju, X., Wang, J., Fan, Y., Ren, M., & Zhang, H. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.08.028 · Cited by 264
Self-citationWan, C., Sun, Y., Tian, Y., Lu, L., Dai, X., Meng, J., Huang, J., He, Q., Wu, B., Zhang, Z., et al. (2020) · Science Advances · doi:10.1126/sciadv.aay9789 · Cited by 251
eIF2α phosphorylation is pathognomonic for immunogenic cell death
Bezu, L., Sauvat, A., Humeau, J., Gomes-da-Silva, L. C., Iribarren, K., Forveille, S., Garcia, P., Zhao, L., Liu, P., Zitvogel, L., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0044-9 · Cited by 241
The Impact of Radiation-Induced DNA Damage on cGAS-STING-Mediated Immune Responses to Cancer
Storozynsky, Q., & Hitt, M. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228877 · Cited by 228
Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology
Vanmeerbeek, I., Sprooten, J., De Ruysscher, D., Tejpar, S., Vandenberghe, P., Fucikova, J., Spisek, R., Zitvogel, L., Kroemer, G., Galluzzi, L., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2019.1703449 · Cited by 227
Suzuki, Y., Mimura, K., Yoshimoto, Y., Watanabe, M., Ohkubo, Y., Izawa, S., Murata, K., Fujii, H., Nakano, T., & Kono, K. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0851 · Cited by 219
Ko, A., Kanehisa, A., Martins, I., Senovilla, L., Chargari, C., Dugue, D., Mariño, G., Kepp, O., Michaud, M., Perfettini, J.-L., et al. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.124 · Cited by 205
Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy
Gao, J., Wang, W.-Q., Pei, Q., Lord, M. S., & Yu, H.-J. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0400-z · Cited by 203
Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy
Adkins, I., Fucikova, J., Garg, A. D., Agostinis, P., & Špíšek, R. (2014) · OncoImmunology · doi:10.4161/21624011.2014.968434 · Cited by 200
Holo-lactoferrin: the link between ferroptosis and radiotherapy in triple-negative breast cancer
Zhang, Z., Lu, M., Chen, C., Tong, X., Li, Y., Yang, K., Lv, H., Xu, J., & Qin, L. (2021) · Theranostics · doi:10.7150/thno.52028 · Cited by 191
Necroptotic cell death in anti‐cancer therapy
Krysko, O., Aaes, T. L., Kagan, V. E., D'Herde, K., Bachert, C., Leybaert, L., Vandenabeele, P., & Krysko, D. V. (2017) · Immunological Reviews · doi:10.1111/imr.12583 · Cited by 173
Lim, S., Park, J., Shim, M. K., Um, W., Yoon, H. Y., Ryu, J. H., Lim, D., & Kim, K. (2019) · Theranostics · doi:10.7150/thno.38425 · Cited by 169
Aaes, T. L., & Vandenabeele, P. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-020-00658-y · Cited by 169
Realizing the Clinical Potential of Immunogenic Cell Death in Cancer Chemotherapy and Radiotherapy
Rapoport, B. L., & Anderson, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040959 · Cited by 164
Garg, A. D., Romano, E., Rufo, N., & Agostinis, P. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.5 · Cited by 152
Stress-induced cellular responses in immunogenic cell death: Implications for cancer immunotherapy
Radogna, F., & Diederich, M. F. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.02.006 · Cited by 149
Damage-associated molecular patterns in tumor radiotherapy
Ashrafizadeh, M., Farhood, B., Musa, A. E., Taeb, S., & Najafi, M. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106761 · Cited by 143
Biomarkers of Radiotherapy-Induced Immunogenic Cell Death
Vaes, R. D. W., Hendriks, L. E. L., Vooijs, M., & Ruysscher, D. D. (2021) · Cells · doi:10.3390/cells10040930 · Cited by 141
Dong, X., Cheng, R., Zhu, S., Liu, H., Zhou, R., Zhang, C., Chen, K., Mei, L., Wang, C., Su, C., et al. (2020) · ACS Nano · doi:10.1021/acsnano.9b08962 · Cited by 139
Chattopadhyay, S., Liu, Y.-H., Fang, Z.-S., Lin, C.-L., Lin, J., Yao, B., & Hu, C. J. (2020) · Nano Letters · doi:10.1021/acs.nanolett.9b04094 · Cited by 130
Rationally Designed Redox-Active Au(I) N-Heterocyclic Carbene: An Immunogenic Cell Death Inducer
Sen, S., Hufnagel, S., Maier, E. Y., Aguilar, I., Selvakumar, J., DeVore, J. E., Lynch, V. M., Arumugam, K., Cui, Z., Sessler, J. L., et al. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c09753 · Cited by 126
Dauer, P., Sharma, N., Gupta, V. K., Durden, B. C., Hadad, R., Banerjee, S., Dudeja, V., Saluja, A. K., & Banerjee, S. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1408-5 · Cited by 124
Kiełbik, M., Szulc-Kiełbik, I., & Klink, M. (2021) · Cells · doi:10.3390/cells10010130 · Cited by 122
Hyperthermia Targeting the Tumor Microenvironment Facilitates Immune Checkpoint Inhibitors
Li, Z., Deng, J., Sun, J., & Ma, Y. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.595207 · Cited by 121
Agonistic CD40 Antibodies in Cancer Treatment
Djureinovic, D., Wang, M., & Kluger, H. M. (2021) · Cancers · doi:10.3390/cancers13061302 · Cited by 119
Antitumor Immunity Induced after α Irradiation
Gorin, J., Ménager, J., Gouard, S., Maurel, C., Guilloux, Y., Faivre-Chauvet, A., Morgenstern, A., Bruchertseifer, F., Chérel, M., Davodeau, F., et al. (2014) · Neoplasia · doi:10.1016/j.neo.2014.04.002 · Cited by 118
Nehs, M. A., Lin, C., Kozono, D., Whang, E. E., Cho, N. L., Zhu, K., Moalem, J., Moore, F. D., & Ruan, D. T. (2011) · Surgery · doi:10.1016/j.surg.2011.09.012 · Cited by 114
The role of toll‐like receptor 4 (TLR4) in cancer progression: A possible therapeutic target?
Kashani, B., Zandi, Z., Pourbagheri‐Sigaroodi, A., Bashash, D., & Ghaffari, S. H. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30166 · Cited by 114
Ferroptosis becomes immunogenic: implications for anticancer treatments
Tang, D., Kepp, O., & Kroemer, G. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1862949 · Cited by 112
Immunogenic Apoptotic Cell Death and Anticancer Immunity
Vandenabeele, P., Vandecasteele, K., Bachert, C., Krysko, O., & Krysko, D. V. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-39406-0_6 · Cited by 109
Schildkopf, P., Frey, B., Ott, O. J., Rubner, Y., Multhoff, G., Sauer, R., Fietkau, R., & Gaipl, U. S. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.05.056 · Cited by 105
P2RX7 Purinoceptor as a Therapeutic Target—The Second Coming?
Young, C., & Górecki, D. C. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00248 · Cited by 101
Singh, A. K., Winslow, T. B., Kermany, M. H., Goritz, V., Heit, L., Miller, A., Hoffend, N. C., Stein, L. C., Kumaraswamy, L. K., Warren, G. W., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2946 · Cited by 93
Radiotherapy and cGAS/STING signaling: Impact on MDSCs in the tumor microenvironment
Kho, V. M., Mekers, V. E., Span, P. N., Bussink, J., & Adema, G. J. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104298 · Cited by 92
Ward, G. A., Lewis, E. J., Ahn, J. S., Johnson, C. N., Lyons, J. F., Martins, V., Munck, J. M., Rich, S. J., Smyth, T., Thompson, N. T., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0848 · Cited by 88
The renaissance of anti‐neoplastic immunity from tumor cell demise
Ma, Y., Pitt, J. M., Li, Q., & Yang, H. (2017) · Immunological Reviews · doi:10.1111/imr.12586 · Cited by 87
Qi, J., Jin, F., Xu, X., & Du, Y. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s285999 · Cited by 86
Roles of low-density lipoprotein receptor-related protein 1 in tumors
Xing, P., Liao, Z., Ren, Z., Zhao, J. L., Song, F., Wang, G., Chen, K., & Yang, J. (2016) · 癌症:英文版 · doi:10.1186/s40880-015-0064-0 · Cited by 80
Stephen, Z. R., & Zhang, M. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202001415 · Cited by 80
Rubner, Y., Muth, C., Strnad, A. R., Derer, A., Sieber, R., Buslei, R., Frey, B., Fietkau, R., & Gaipl, U. S. (2014) · Radiation Oncology · doi:10.1186/1748-717x-9-89 · Cited by 76
Huang, K. C., Chiang, S., Ke, T., Chen, T.-W., Lan, Y., You, Y., Shiau, A., Chen, W. T., & Chao, K. S. C. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-2109-5 · Cited by 74
The inducers of immunogenic cell death for tumor immunotherapy
Li, X. (2017) · Tumori Journal · doi:10.5301/tj.5000675 · Cited by 71
Huang, Y., Dong, Y., Zhao, J., Zhang, L., Kong, L., & Lu, J. J. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.09.128 · Cited by 70
Stangl, S., Tontcheva, N., Sievert, W., Shevtsov, M. A., Niu, M., Schmid, T. E., Pigorsch, S. U., Combs, S. E., Haller, B., Balermpas, P., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.31213 · Cited by 69
Enhancing the efficacy of immunotherapy using radiotherapy
Keam, S., Gill, S., Ebert, M. A., Nowak, A. K., & Cook, A. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1169 · Cited by 69
Werthmöller, N., Frey, B., Rückert, M., Lotter, M., Fietkau, R., & Gaipl, U. S. (2016) · International Journal of Hyperthermia · doi:10.3109/02656736.2015.1106011 · Cited by 68
Regulated Necrotic Cell Death in Alternative Tumor Therapeutic Strategies
Woo, Y., Lee, H.-J., Jung, Y. M., & Jung, Y. (2020) · Cells · doi:10.3390/cells9122709 · Cited by 68
Rothammer, A., Sage, E. K., Werner, C., Combs, S. E., & Multhoff, G. (2019) · Radiation Oncology · doi:10.1186/s13014-019-1286-0 · Cited by 66
Choi, B., Choi, H., Yu, B., & Kim, D. (2020) · ACS Nano · doi:10.1021/acsnano.0c04701 · Cited by 63
Xiao, R., Allen, C. T., Tran, L. B., Patel, P., Park, S. J., Chen, Z., Waes, C. V., & Schmitt, N. C. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1471440 · Cited by 62
Schildkopf, P., Frey, B., Mantel, F., Ott, O. J., Weiss, E., Sieber, R., Janko, C., Sauer, R., Fietkau, R., & Gaipl, U. S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.008 · Cited by 61
Janic, B., Brown, S. L., Neff, R. A., Liu, F., Mao, G., Chen, Y., Jackson, L., Chetty, I. J., Movsas, B., & Wen, N. W. (2021) · Cancer Biology & Therapy · doi:10.1080/15384047.2020.1861923 · Cited by 59
An emerging role for nanomaterials in increasing immunogenicity of cancer cell death
Mishchenko, T. A., Mitroshina, Е. V., Balalaeva, I. V., Krysko, O., Vedunova, M. V., & Krysko, D. V. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.11.004 · Cited by 55
Ye, W., Gunti, S., Allen, C. T., Hong, Y., Clavijo, P. E., Waes, C. V., & Schmitt, N. C. (2020) · OncoImmunology · doi:10.1080/2162402x.2019.1710398 · Cited by 53
Defining Molecular Signature of Pro-Immunogenic Radiotherapy Targets in Human Prostate Cancer Cells
Aryankalayil, M. J., Makinde, A. Y., Gameiro, S. R., Hodge, J. W., Rivera-Solis, P. P., Palayoor, S. T., Ahmed, M. M., & Coleman, C. N. (2014) · Radiation Research · doi:10.1667/rr13731.1 · Cited by 50
Wang, H.-H., Wu, Z.-Q., Qian, D., Zaorsky, N. G., Qiu, M.-H., Cheng, J.-J., Jiang, C., Wang, J., Zeng, X.-L., Liu, C.-L., et al. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.01.036 · Cited by 49
Radiotherapy as a Backbone for Novel Concepts in Cancer Immunotherapy
Kabiljo, J., Harpain, F., Carotta, S., & Bergmann, M. M. (2019) · Cancers · doi:10.3390/cancers12010079 · Cited by 49
Yin, Y., Cao, W., Zhou, H., Qian, H., & Wang, H. (2021) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.12.062 · Cited by 47
Self-citationYoo, G. S., Ahn, W.-G., Kim, S., Kang, W., Choi, C., & Park, H. C. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0095 · Cited by 45
Ye, J., Mills, B. N., Zhao, T., Han, B. J., Murphy, J. D., Patel, A. P., Johnston, C. J., Lord, E. M., Belt, B. A., Linehan, D. C., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0373 · Cited by 43
HMGB1 in Radiotherapy: A Two Headed Signal Regulating Tumor Radiosensitivity and Immunity
Liao, Y., Liu, S., Fu, S., & Wu, J. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s253772 · Cited by 41
Qin, X., Liu, J., Xu, Y., Li, B., Cheng, J., Wu, X., Zhang, J., Liu, Z., Ning, R., Li, Y., et al. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c08074 · Cited by 38
Self-citationTherapy-Induced Tumor Cell Death: Friend or Foe of Immunotherapy?
van Schaik, T., Chen, K., & Shah, K. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.678562 · Cited by 38
Bip inhibition in glioma stem cells promotes radiation-induced immunogenic cell death
Yang, W., Xiu, Z., He, Y., Huang, W., Li, Y., & Sun, T. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03000-z · Cited by 33
Autophagy-regulating microRNAs: potential targets for improving radiotherapy
Li, H., Jin, X., Chen, B., Li, P., & Li, Q. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2675-8 · Cited by 32
Kashkoulinejad-Kouhi, T., Safarian, S., Arnáiz, B., & Saá, L. (2020) · Oncology Reports · doi:10.3892/or.2020.7898 · Cited by 32
Welsh, J. S., Bevelacqua, J. J., Dobrzyński, L., Mortazavi, S. M. J., Farjadian, S., & Mortazavi, S. M. J. (2019) · Journal of Biomedical Physics and Engineering · doi:10.31661/jbpe.v0i0.1066 · Cited by 24
Radiation biology considerations of proton therapy for gastrointestinal cancers
Beltran, C. J., Schultz, H. L., Anand, A., et al. (2020) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2019.06.08 · Cited by 11
Sridharan, V., & Schoenfeld, J. D. (2019) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2019.08.001 · Cited by 5
Cited by
Liu, J., Guo, L., Mi, Z., Liu, Z., Rong, P., & Zhou, W. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.06.030 · Cited by 40
Radiotherapy and radiosensitization in breast cancer: Molecular targets and clinical applications
Bhat, V., Pellizzari, S., Allan, A. L., Wong, E., Lock, M., Brackstone, M., Lohmann, A. E., Cescon, D. W., & Parsyan, A. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103566 · Cited by 31
Metadata
- Authors
- Zhu, M., Yang, M., Zhang, J., Yin, Y., Fan, X., Zhang, Y., Qin, S., Zhang, H., & Yu, F.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2021-08-20
- Volume
- 12
- Pages
- 705361-705361
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3195685486
- Cited by
- 291
- References
- 93
- FWCI
- 12.64
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.